12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's after-market session, several health care stocks experienced significant price movements. Notable gainers included Tevogen Bio Holdings, Allakos, and Unicycive Therapeutics, while Akanda, Dogwood Therapeutics, and Nexalin Technology were among the losers.
October 11, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Allakos stock rose by 5.75% in the after-market session, reflecting positive investor sentiment.
The increase in Allakos' stock price suggests positive sentiment, which may continue to drive the stock upwards in the short term.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Tevogen Bio Holdings saw a significant increase of 89.7% in its stock price during Friday's after-market session.
The substantial rise in Tevogen Bio Holdings' stock price indicates strong investor interest or positive news, likely leading to continued upward momentum in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Unicycive Therapeutics' stock increased by 5.4% in the after-market session.
The rise in Unicycive Therapeutics' stock price indicates a positive outlook, potentially leading to further gains.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 70
NEGATIVE IMPACT
Akanda's stock fell by 8.4% in the after-market session, indicating negative investor sentiment.
The decline in Akanda's stock price suggests negative sentiment, which may lead to further downward pressure in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Dogwood Therapeutics' stock decreased by 7.79% in the after-market session.
The drop in Dogwood Therapeutics' stock price indicates negative sentiment, potentially leading to further declines.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Nexalin Technology's stock declined by 7.56% in the after-market session.
The decrease in Nexalin Technology's stock price suggests a negative outlook, which may continue to impact the stock negatively.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 70